Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

This publication has 54 references indexed in Scilit:

• In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions
  Journal of Biological Chemistry, 2004
• Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages
  Blood, 2003
• Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial
  European Journal of Clinical Investigation, 2003
• Novel Mode of Interference with Nuclear Factor of Activated T-cells Regulation in T-cells by the Bacterial Metaboliten-Butyrate
  Journal of Biological Chemistry, 2002
• Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis
  Scandinavian Journal of Gastroenterology, 2002
• Anti‐inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL‐12 and up‐regulation of IL‐10 production
  The FASEB Journal, 2000
• The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells
  Innate Immunity, 2000
• Epigenetic Regulation of Gelsolin Expression in Human Breast Cancer Cells
  Experimental Cell Research, 1999
• Differential Expression of Human Histone Deacetylase mRNAs in Response to Immune Cell Apoptosis Induction by Trichostatin A and Butyrate
  Biochemical and Biophysical Research Communications, 1998
• Transcription Factor Loading on the MMTV Promoter: A Bimodal Mechanism for Promoter Activation
  Science, 1992